About this episode

The episode discusses the widespread use of GLP-1 drugs and their unexpected benefits beyond approved uses.

GLP-1 drugs like Ozempic and Wegovy are being taken by millions of Americans. These medications have been approved for treating diabetes, obesity, and a small number of other chronic conditions. But even as experts are still learning how the drugs work, many people have found that they help with other disorders — from addiction to brain fog to arthritis — where anecdotal evidence is promising but the formal research hasn’t caught up. Julia Belluz , a contributing writer for the New York Times Opinion section and coauthor of Food Intelligence , joins Apple News In Conversation guest host David Greene to explain why what’s unfolding right now may be the largest uncontrolled drug experiment in modern history.

People in this episode

Host: David Greene

Guest: Julia Belluz

Topics covered

• GLP-1 drugs
• health experiments
• diabetes treatment
• obesity medication
• chronic conditions
• anecdotal evidence

Keywords

• GLP-1
• Ozempic
• Wegovy
• health
• experiments
• addiction
• brain fog
• arthritis

Mentioned in this episode

Organizations: New York Times

Products: Ozempic, Wegovy

More episodes of Apple News In Conversation

• The surprising ways the Supreme Court curbed Trump’s power · July 9, 2026 · 24 min
• Why the Constitution is making our politics worse (From the archives) · July 2, 2026 · 30 min
• The little-known forces quietly killing the college degree · June 25, 2026 · 25 min
• The U.S. is turning 250. These songs unexpectedly changed American history. · June 18, 2026 · 24 min

Explore listener stats, chart rankings, contacts and more on the Apple News In Conversation podcast page.